Compared with the CTX group, the expression levels of MMP-9, MMP-2, VEGF, bFGF, Bax, and Bcl-2 in tumor tissues were reversed by 47%, 72%, 49%, 60%, 57%, and 48%, respectively, after high-dose GFG combined with CTX treatment. The gene discussed is BCL2; the disease is neoplasm.